Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium.
Choudhury P, Lee-Iannotti JK, Busicescu AO, Rangan P, Fantini ML, Avidan AY, Bliwise DL, Criswell SR, During EH, Elliott JE, Fields JA, Gagnon JF, Howell MJ, Huddleston DE, McLeland J, Mignot E, Miglis MG, Lim MM, Pelletier A, Schenck CH, Shprecher D, St Louis EK, Videnovic A, Ju YS, Boeve BF, Postuma R; as the NAPS Consortium.
Choudhury P, et al. Among authors: miglis mg.
Neurology. 2024 Feb 13;102(3):e208008. doi: 10.1212/WNL.0000000000208008. Epub 2024 Jan 5.
Neurology. 2024.
PMID: 38181331